Litigation
Untitled case
Litigation4:19-cv-05924
Patents at issue (1)
Summary
A US patent litigation case filed in the California Northern District Court with docket number 4:19-cv-05924.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Case Overview and Background for Omni MedSci, Inc. v. Apple Inc.
This patent infringement lawsuit, case number 4:19-cv-05924, was filed by Omni MedSci, Inc. against Apple Inc. in the U.S. District Court for the Northern District of California. The case is presided over by Judge Yvonne Gonzalez Rogers. Omni MedSci, Inc. is a patent assertion entity (PAE) founded by Professor Mohammed Islam, the sole named inventor of the asserted patents. Apple Inc. is a major technology operating company known for its consumer electronics, software, and online services. The litigation centers on alleged infringement of US Patent No. 9,651,533. While the specific accused products in this particular case are not explicitly detailed in the search results, related litigation by Omni MedSci against other companies like WHOOP, Inc. and Samsung Elecs. Co. concerning similar patents suggests the accused technology likely involves wearable health monitoring devices or related optical sensing functionalities. US Patent No. 9,651,533 broadly covers short-wave infrared super-continuum lasers for applications such as detecting counterfeit drugs or for pharmaceutical process control, suggesting a focus on optical spectroscopy for material analysis or sensing.
The procedural posture of this case has included significant disputes over standing, with Apple challenging Omni MedSci's right to sue, arguing that the University of Michigan, where Professor Islam is a tenured professor, held the patent rights. This standing issue was the subject of an appeal to the Federal Circuit. The Northern District of California is a notable venue for patent litigation, particularly for defendants like Apple, as it is known for its experienced judges, efficient handling of complex litigation, and favorable view towards early dispositive motions, such as Alice motions challenging patent eligibility, and motions to stay cases pending inter partes review (IPR) proceedings at the USPTO. Indeed, IPRs have been filed challenging Omni MedSci's patents, including the 9,055,868 patent mentioned in related proceedings. The case's notability stems from its connection to a patent assertion entity, the involvement of a major tech company like Apple, and the recurring theme of patent eligibility and ownership tied to university employment agreements, which often arise in cases involving academic inventors. The ongoing IPR challenges also highlight a common defense strategy against PAE assertions.
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Key Legal Developments and Outcome for Omni MedSci, Inc. v. Apple Inc. (4:19-cv-05924)
This patent infringement litigation, originally filed in the Eastern District of Texas and later transferred to the Northern District of California, has seen significant activity, particularly around the plaintiff's standing and parallel PTAB proceedings. The case involves U.S. Patent 9,651,533, among other patents.
Filing & Initial Pleadings:
The case was initially filed by Omni MedSci, Inc. against Apple Inc. in the Eastern District of Texas. It was subsequently transferred to the Northern District of California, with case number 4:19-cv-05924. While the exact complaint filing date in the Eastern District of Texas is not explicitly provided in the search results, the case was transferred to the Northern District of California by November 2019. Initial pleadings likely included Omni MedSci's complaint alleging patent infringement and Apple's answer, which included a motion to dismiss for lack of standing.
Pre-trial Motions of Substance:
A significant pre-trial development was Apple's motion to dismiss the complaint for lack of standing. Apple argued that the University of Michigan (UM) bylaws automatically transferred legal title of the patents at issue from Dr. Islam (the inventor) to UM, thus leaving Dr. Islam with no rights to assign to Omni MedSci, and consequently, Omni MedSci lacked standing to sue. The Eastern District of Texas denied this motion, concluding that the bylaw was not a present automatic assignment of title but rather a statement of a future intention to assign.
After the case was transferred to the Northern District of California, Apple filed for reconsideration of the standing decision, which the district court denied on November 25, 2019. The Northern District of California then granted Apple's unopposed motion for certification of the standing question to the Federal Circuit on February 14, 2020.
Appeal of Motion to Dismiss (Standing):
Apple appealed the denial of its motion to dismiss to the Federal Circuit. On August 2, 2021, the Federal Circuit affirmed the district court's holding, ruling that the University of Michigan bylaws did not effectuate a present automatic assignment of Dr. Islam's patent rights. Therefore, Omni MedSci had standing to assert the patents.
Parallel PTAB IPR Proceedings:
By July 2019, Apple had filed six Inter Partes Review (IPR) petitions directed to the at-issue patents. The search results do not specify the outcomes of these IPRs or their direct effect on the litigation's current posture, though it is noted that the University of Michigan failed to file mandatory notices in these IPRs despite Apple serving the petitions on them, implying UM's inaction regarding its purported ownership. The specific status or resolution of IPRs relating to patent 9,651,533 would require a direct search of the USPTO's P-TACTS system.
Further Developments and Outcome:
Detailed information regarding claim construction (Markman) outcomes, specific discovery milestones, trial events, verdicts, post-trial motions, settlement, or final judgment is not readily available in the provided search results beyond the resolution of the standing issue. The case appears to have continued after the Federal Circuit's decision on standing in August 2021. However, the exact current disposition (e.g., active litigation, settlement, dismissal, or further appeal) after that point is not detailed. To ascertain the most recent developments and final outcome, a more recent docket search would be necessary.
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
- Hahn Loeser & Parks
- Steven E. Feldman · Lead Counsel
- Patterson Thuente IP
- David P. Swenson · Counsel
- Brooks Kushman
- Thomas A. Lewry · Counsel
- John S. LeRoy · Counsel
- Christopher C. Smith · Counsel
I apologize, it seems there was an error in the tool code. I will correct it and proceed with identifying the counsel of record for the plaintiff.This section identifies the counsel of record representing Omni MedSci, Inc. in the patent infringement case 4:19-cv-05924 against Apple Inc.
Plaintiff's Counsel: Omni MedSci, Inc.
Steven E. Feldman
- Role: Lead Counsel. He is the head of Hahn Loeser's Intellectual Property Practice Area and the Partner-in-Charge of the firm's Chicago office.
- Firm: Hahn Loeser & Parks LLP, Chicago, IL.
- Experience Note: Mr. Feldman focuses on complex intellectual property litigation, prosecution, and counseling involving patents, trade secrets, trademarks, and unfair competition. He has extensive experience in chemical and pharmaceutical cases, including Hatch-Waxman litigation, and has taken a lead role in trials, Markman hearings, and appeals. His technical background is in materials science and engineering. He was previously with Latham & Watkins LLP, where he was a partner in the Litigation & Trial Department and a member of the Complex Commercial Litigation Practice, based in Los Angeles and New York. He has secured trial victories in trade secret, fiduciary duty, and competitor disputes, as well as patent, Lanham Act, and consumer class action victories for clients like Peloton Interactive.
David P. Swenson
- Role: Counsel. He is the Litigation Practice Chair at Patterson Thuente IP.
- Firm: Patterson Thuente IP, Minneapolis, MN. (Previously with Robins, Kaplan, Miller & Ciresi LLP)
- Experience Note: Mr. Swenson is an intellectual property litigator with extensive experience in trial courts nationwide and before the U.S. Court of Appeals for the Federal Circuit. He has a background in computer science and has handled patent litigation across a wide range of technologies, including microchips, routers, and internet browsers. He has also achieved notable appellate successes, including convincing the U.S. Supreme Court to vacate PTAB inter partes review (IPR) decisions in Gramm v. Deere & Co.
Thomas A. Lewry
- Role: Counsel.
- Firm: Brooks Kushman P.C., Southfield, MI.
- Experience Note: Mr. Lewry argued for Omni MedSci, Inc. as plaintiff-appellee in the Federal Circuit regarding the standing issue in Omni MedSci, Inc. v. Apple Inc.
John S. LeRoy
- Role: Counsel.
- Firm: Brooks Kushman P.C., Southfield, MI.
- Experience Note: Listed as appearing for Omni MedSci, Inc. in the Federal Circuit appeal concerning standing.
Christopher C. Smith
- Role: Counsel.
- Firm: Brooks Kushman P.C., Southfield, MI.
- Experience Note: Listed as appearing for Omni MedSci, Inc. in the Federal Circuit appeal concerning standing.
It should be noted that in some earlier filings and appeals related to the standing issue, Brooks Kushman P.C. attorneys, including Thomas A. Lewry, John S. LeRoy, and Christopher C. Smith, represented Omni MedSci, Inc. While Steven E. Feldman and David P. Swenson's current roles are clear from their firm profiles, the most recent comprehensive docket entry for counsel of record was not immediately available through direct web search, thus relying on Federal Circuit appellate briefs for some attorney appearances.
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
- Sidley Austin
- Jeffrey Paul Kushan · Lead Counsel
- Joshua John Fougere · Counsel
- Brooke Shanelle Boll · Counsel
- Michael Roberts · Counsel
- Irene Yang · Counsel
- Apple Inc.
- Iain Cunningham · Senior Litigation Counsel
- Jeff Myers · Chief IP Counsel
The previous search has an error. Let's correct it and search for the counsel representing Apple Inc. in case 4:19-cv-05924 in the Northern District of California.
In Omni MedSci, Inc. v. Apple Inc. (4:19-cv-05924), the defendant, Apple Inc., has been represented by counsel from Sidley Austin LLP and by its in-house legal team.
Here's a breakdown of the counsel of record for Apple:
Jeffrey Paul Kushan
- Role: Lead Counsel (argued for defendant-appellant at the Federal Circuit)
- Firm: Sidley Austin LLP, Washington, DC
- Note: Mr. Kushan is a partner at Sidley Austin and has extensive experience in patent litigation, particularly in appeals before the Federal Circuit.
Joshua John Fougere
- Role: Counsel
- Firm: Sidley Austin LLP
- Note: Mr. Fougere is a partner at Sidley Austin focusing on intellectual property litigation.
Brooke Shanelle Boll
- Role: Counsel
- Firm: Sidley Austin LLP, Los Angeles, CA
Michael Roberts
- Role: Counsel
- Firm: Sidley Austin LLP, Dallas, TX
Irene Yang
- Role: Counsel
- Firm: Sidley Austin LLP, San Francisco, CA
Apple also employs a robust in-house legal team for intellectual property litigation. While specific individuals from Apple's in-house counsel may not be listed on every docket entry, they play a crucial role in driving litigation strategy and managing disputes.
Iain Cunningham
- Role: Senior Litigation Counsel, Apple (as of 2015, likely involved in managing patent litigation)
- Firm: Apple Inc. (in-house)
- Note: Mr. Cunningham is Senior Litigation Counsel at Apple, with a focus on patent litigation.
Jeff Myers
- Role: Chief IP Counsel, Apple (likely oversees patent litigation strategy)
- Firm: Apple Inc. (in-house)
- Note: Mr. Myers serves as Chief IP Counsel at Apple and has been involved in protecting Apple's products and innovations for many years.